Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell line

被引:16
|
作者
Matsuda, H
Kinoshita, K
Sumida, A
Takahashi, K
Fukuen, S
Fukuda, T
Takahashi, K
Yamamoto, I
Azuma, J
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan
[2] Mukogawa Womens Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Nishinomiya, Hyogo, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2002年 / 1593卷 / 01期
基金
日本学术振兴会;
关键词
taurine; CYP3A4; CYP mRNA; RT-competitive PCR; induction; HepG2; cell;
D O I
10.1016/S0167-4889(02)00345-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Taurine is not only present in foods, tonics and nutrient drinks but is also used as a medicinal agent mainly for treatment of chronic heart failure and liver disease. However, little is known about its influence on drug-metabolizing enzymes, especially cytochrome P450 (CYP), in human. We examined whether. taurine could affect the expression of CYP3A4 mRNA in the presence or absence of rifampicin (RFP), which is a potent inducer of CYPs, with HepG2 cells. Taurine enhanced twice the induction of CYP3A4 mRNA by RFP, but did not affect the expression by itself. This effect was both concentration- and time-dependent. On the other hand, taurine did not affect the induction by phenobarbital. Taurine did not increase intracellular uptake of RFP. Therefore, we conclude that taurine is an enhancer for the induction of CYP3A4 by RFP. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 50 条
  • [1] Taurine modulates catalytic activity of cytochrome P450 3A4
    Shumyantseva, V. V.
    Makhova, A. A.
    Bulko, T. V.
    Bernhardt, R.
    Kuzikov, A. V.
    Shich, E. V.
    Kukes, V. G.
    Archakov, A. I.
    BIOCHEMISTRY-MOSCOW, 2015, 80 (03) : 366 - 373
  • [2] Taurine modulates catalytic activity of cytochrome P450 3A4
    V. V. Shumyantseva
    A. A. Makhova
    T. V. Bulko
    R. Bernhardt
    A. V. Kuzikov
    E. V. Shich
    V. G. Kukes
    A. I. Archakov
    Biochemistry (Moscow), 2015, 80 : 366 - 373
  • [3] Modulation of taurine on CYP3A4 induction by rifampicin in a HepG2 cell line
    Takahashi, K
    Matsuda, H
    Kinoshita, K
    Matsunaga, N
    Sumita, A
    Matsuda, T
    Takahashi, K
    Azuma, J
    TAURINE 5: BEGINNING THE 21ST CENTURY, 2003, 526 : 237 - 244
  • [4] Peppermint (Mentha piperita L.) extract effectively inhibits cytochrome P450 3A4 (CYP3A4) mRNA induction in rifampicin-treated HepG2 cells
    Kobayashi, Tsukasa
    Sugaya, Kouichi
    Onose, Jun-Ichi
    Abe, Naoki
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2019, 83 (07) : 1181 - 1192
  • [5] Effect of bixin and norbixin on the expression of cytochrome P450 in HepG2 cell line
    Sakuragui Matuo, Miriam Cristina
    de Oliveira Takamoto, Rafael Teruiti
    Kikuchi, Irene Satiko
    Andreoli Pinto, Terezinha de Jesus
    CELL BIOLOGY INTERNATIONAL, 2013, 37 (08) : 843 - 848
  • [6] Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes
    Roymans, D
    Van Looveren, C
    Leone, A
    Parker, JB
    McMillian, M
    Johnson, MD
    Koganti, A
    Gilissen, R
    Silber, P
    Mannens, G
    Meuldermans, W
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (03) : 427 - 437
  • [7] Novel plant inducers of PXR-dependent cytochrome P450 3A4 expression in HepG2 cells
    Al-Dosari, Mohammed S.
    Parvez, Mohammad K.
    SAUDI PHARMACEUTICAL JOURNAL, 2018, 26 (08) : 1069 - 1072
  • [8] Structures of cytochrome P450 3A4
    Scott, EE
    Halpert, JR
    TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (01) : 5 - 7
  • [9] Salinomycin induces cell cycle arrest and apoptosis and modulates hepatic cytochrome P450 mRNA expression in HepG2/C3a cells
    Niwa, Andressa Megumi
    Semprebon, Simone Cristine
    D'Epiro, Glaucia Fernanda Rocha
    Marques, Lilian Areal
    Zanetti, Thalita Alves
    Mantovani, Mario Sergio
    TOXICOLOGY MECHANISMS AND METHODS, 2022, 32 (05) : 341 - 351
  • [10] HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics
    Choi, Jong Min
    Oh, Soo Jin
    Lee, Sang Yoon
    Im, Ji Hye
    Oh, Jung Min
    Ryu, Chang Seon
    Kwak, Hui Chan
    Lee, Ji-Yoon
    Kang, Keon Wook
    Kim, Sang Kyum
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (05) : 691 - 704